CD226 and neoplasm: Notably, CAR-NK cells can kill tumor cells even in a CAR-independent manner by their native receptors (including NCRs, NKG2D, DNAM-1, and activating KIRs), counteracting tumor escape mechanism due to lack of CAR-targeted antigen.